MEDRx USA is a subsidiary whole owned by Medrx Co., Ltd. that is listed on Tokyo Stock Exchange “Mothers”.
MEDRx is the world's first pharmaceutical company capitalizing on ionic liquid
technology for transdermal delivery(ILTS®).
ILTS® allows compounds with weak absorbability and/or low solubility to be available as transdermal preparations by means of increasing their solubility and absorbability dramatically.
Informations about Medrx Co., Ltd. are here.